Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
Year: 2026
Type: article
Study design: Observational Study
Source: Blood
Authors: Mark R. Dowling, Edward R. Scheffer Cliff, Anthony Jeffrey, Catelyn Cashion, Stephen Boyle, Jian Li, Thomas Buss, Ross MacDonald, Anastasia Edelkina, Hamish W. Scott, Nicole L. O’Leary, Michelle W. Keir, Safia Belbachir, David A. Westerman, Constantine S. Tam, P. Joy Ho, Simon J. Harrison, Allison Barraclough, Shafqat Inam, Emily Blyth, Andrea S. Henden, Vinay Vanguru, Michael J. Dickinson
Institutions: The Royal Melbourne Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, The University of Sydney, Royal Prince Alfred Hospital, Westmead Hospital, The University of Queensland, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service, The Alfred Hospital, Monash University, Fiona Stanley Hospital, Fiona Stanley Fremantle Hospitals Group, Westmead Institute for Medical Research
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129234072